Stay updated on BMN 110 Phase 3B in Australian Patients Clinical Trial
Sign up to get notified when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.

Latest updates to the BMN 110 Phase 3B in Australian Patients Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedUpdated the disease terminology from 'Mucopolysaccharidosis type 4A' to 'Mucopolysaccharidosis, MPS-IV-A' across the study page.SummaryDifference0.1%

- Check28 days agoChange Detected- Site revision updated from v3.4.3 to v3.5.0. - No visible changes to study content or layout.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding notice and Revision: v3.4.1 text; these are administrative changes that do not affect the study content or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedA site-wide notice about a lapse in government funding and current operations was added, directing users to cc.nih.gov and opm.gov, and the page version was updated from 3.4.0 to 3.4.1.SummaryDifference0.5%

- Check78 days agoChange DetectedAdditions: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These updates are administrative and do not affect study data or user actions; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to BMN 110 Phase 3B in Australian Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.